JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
JNCE
Delisted
JNCE was delisted on the 3rd of May, 2023.
85 hedge funds and large institutions have $39M invested in Jounce Therapeutics, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 25 increasing their positions, 30 reducing their positions, and 24 closing their positions.
Holders
85
Holders Change
-17
Holders Change %
-16.67%
% of All Funds
1.37%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
10
Increased
25
Reduced
30
Closed
24
Calls
$9K
Puts
$6K
Net Calls
+$3K
Net Calls Change
-$272K
Top Buyers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
101
Balyasny Asset Management
Chicago,
Illinois
| – | – | -11,177 | Closed |
|
|
ACM
102
Aquatic Capital Management
Chicago,
Illinois
| – | – | -10,100 | Closed |
|
|
BRA
103
Bender Robert & Associates
Pasadena,
California
| – | – | -10,000 | Closed |
|
104
First Manhattan
New York
| – | – | -6,400 | Closed |
|
105
Zurich Cantonal Bank
Zurich,
Switzerland
| – | – | -3,420 | Closed |
|
106
Group One Trading
Chicago,
Illinois
| – | – | -2,334 | Closed |
|
|
CUAMC
107
China Universal Asset Management Company
Shanghai,
China
| – | – | -484 | Closed |
|
|
PHK
108
Point72 Hong Kong
Hong Kong
| – | – | -355 | Closed |
|
109
Daiwa Securities Group
Tokyo,
Japan
| – | – | -75 | Closed |
|
|
PVI
110
Pura Vida Investments
New York
| – | – | – | – |
|
|
CFGS
111
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|